title: Treatment of Stage IIIA Non-Small-Cell Lung Cancer: A Concise Review for the Practicing Oncologist.
abstract: Stage IIIA non-small-cell lung cancer occurs in a heterogenous group of patients for whom the best treatment is multimodality therapy with chemotherapy, radiation, and surgery in a select group of individuals. This clinical review intends to answer the most common questions that clinicians face in the decision about the best management in this group.
authors.affiliation: University of Washington, Seattle, WA rafaelsd@u.washington.edu.
authors.forename: Rafael
authors.initials: R
authors.lastname: Santana-Davila
authors.affiliation: University of Washington, Seattle, WA.
authors.forename: Renato
authors.initials: R
authors.lastname: Martins
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy; D008175:Lung Neoplasms / Q000628:therapy*; D058990:Molecular Targeted Therapy; D009364:Neoplasm Recurrence, Local / Q000628:therapy; D009367:Neoplasm Staging; D000072103:Oncologists; D011829:Radiation Dosage